(Q40869093)

24 September 2017

1 reference

title

Traction retinal detachment. XLIX Edward Jackson Memorial Lecture (English)

1 reference

24 September 2017

S J Ryan

1

1 reference

PubMed ID

8420359

24 September 2017

language of work or name

English

0 references

publication date

1 January 1993

1 reference

American Journal of Ophthalmology

24 September 2017

1 reference

24 September 2017

115

1 reference

24 September 2017

1

1 reference

24 September 2017

1-20

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2973518-4

24 September 2017

1 reference

7 January 2021

Penetrating ocular injuries. Types of injuries and visual results

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2973518-4

7 January 2021

Experimental posterior penetrating eye injury in the rabbit. I. Method of production and natural history

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2973518-4

7 January 2021

Experimental posterior penetrating eye injury in the rabbit. II. Histology of wound, vitreous, and retina

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2973518-4

7 January 2021

Method of Production and Natural History of Experimental Posterior Penetrating eye Injury in the Rhesus Monkey

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2973518-4

7 January 2021

Experimental posterior penetrating eye injury in the rhesus monkey: vitreous-lens admixture

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2973518-4

7 January 2021

Mechanisms in Traction Retinal Detachment

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2973518-4

7 January 2021

Combined posterior contusion and penetrating injury in the pig eye. II. Histological features

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2973518-4

7 January 2021

Vitrectomy in penetrating eye injury. Results of a controlled trial of vitrectomy in an experimental posterior penetrating eye injury in the rhesus monkey

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2973518-4

7 January 2021

Ultrastructure of traction retinal detachment in rhesus monkey eyes after a posterior penetrating ocular injury.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2973518-4

7 January 2021

Effect of fibrin on morphologic characteristics of retinal pigment epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2973518-4

7 January 2021

Effect of vitreous on morphologic characteristics of retinal pigment epithelial cells. A new approach to the study of proliferative vitreoretinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2973518-4

7 January 2021

Combined posterior contusion and penetrating injury in the pig eye. III. A controlled treatment trial of vitrectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2973518-4

7 January 2021

Platelet-derived growth factor is chemotactic for human retinal pigment epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2973518-4

7 January 2021

Serum contains chemoattractants for human retinal pigment epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2973518-4

7 January 2021

Growth factors in retinal diseases: proliferative vitreoretinopathy, proliferative diabetic retinopathy, and retinal degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2973518-4

7 January 2021

Early vitrectomy in the management of the severely traumatized eye

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2973518-4

7 January 2021

Pars Plana Vitrectomy in Ocular Trauma

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2973518-4

7 January 2021

Pars plana vitrectomy for severe penetrating injury with posterior segment involvement

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2973518-4

7 January 2021

Timing of vitrectomy after penetrating ocular injuries

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2973518-4

7 January 2021

Guidelines in the management of penetrating ocular trauma with emphasis on the role and timing of pars plana vitrectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2973518-4

7 January 2021

Factors influencing final visual results in severely injured eyes

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2973518-4

7 January 2021

Surgical results in ocular trauma involving the posterior segment

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2973518-4

7 January 2021

Cryotherapy enhances intravitreal dispersion of viable retinal pigment epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2973518-4

7 January 2021

Proliferative vitreoretinopathy. The mechanism of development of vitreoretinal traction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2973518-4

7 January 2021

Cytokines in proliferative vitreoretinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2973518-4

7 January 2021

The classification of retinal detachment with proliferative vitreoretinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2973518-4

7 January 2021

Classification of proliferative vitreoretinopathy used in the silicone study. The Silicone Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2973518-4

7 January 2021

An updated classification of retinal detachment with proliferative vitreoretinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2973518-4

7 January 2021

Proliferative vitreoretinopathy--is it anything more than wound healing at the wrong place?

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2973518-4

7 January 2021

Immunohistologic Study of Epiretinal Membranes in Proliferative Vitreoretinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2973518-4

7 January 2021

Proliferative vitreoretinopathy membranes. An immunohistochemical study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2973518-4

7 January 2021

Mechanisms involved in retinal pigment epithelial cell chemotaxis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2973518-4

7 January 2021

Macrophage modulation of retinal pigment epithelial cell migration and proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2973518-4

7 January 2021

Basic Fibroblast Growth Factor Levels in the Vitreous of Patients With Proliferative Diabetic Retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2973518-4

7 January 2021

Retinal pigment epithelial cells produce PDGF-like proteins and secrete them into their media

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2973518-4

7 January 2021

Growth factors in the eye.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2973518-4

7 January 2021

Retinal pigment epithelial cells produce fibronectin

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2973518-4

7 January 2021

Proteins of the extracellular matrix in vitreoretinal membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2973518-4

7 January 2021

Cytoskeleton, adhesion, and extracellular matrix of fetal human retinal pigmented epithelial cells in culture

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2973518-4

7 January 2021

The pathophysiology of proliferative vitreoretinopathy in its management

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2973518-4

7 January 2021

Proliferative vitreoretinopathy: the rabbit cell injection model for screening of antiproliferative drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2973518-4

7 January 2021

A comparison of different cellular inocula in an experimental model of massive periretinal proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2973518-4

7 January 2021

Control of experimental massive periretinal proliferation by daunomycin: dose-response relation

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2973518-4

7 January 2021

Antiproliferative drugs in the treatment of experimental proliferative vitreoretinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2973518-4

7 January 2021

Long-term results of vitrectomy and perfluorocarbon gas for the treatment of severe proliferative vitreoretinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2973518-4

7 January 2021

Vitrectomy with silicone oil or sulfur hexafluoride gas in eyes with severe proliferative vitreoretinopathy: results of a randomized clinical trial. Silicone Study Report 1

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2973518-4

7 January 2021

Perfluoro-octane in the Treatment of Giant Retinal Tears with Proliferative Vitreoretinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2973518-4

7 January 2021

The Use of Liquid Silicone in Retinal Detachment Surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2973518-4

7 January 2021

Methods, statistical features, and baseline results of a standardized, multicentered ophthalmologic surgical trial: The silicone study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2973518-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2973518-4

1 reference

7 January 2021

Demonstration of vasoproliferative activity from mammalian retina

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2973518-4

7 January 2021

Vitreous contraction in proliferative diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2973518-4

7 January 2021

Biomicroscopic study of vitreous cavity in diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2973518-4

7 January 2021

Posterior vitreous detachment in diabetic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2973518-4

7 January 2021

Pathogenesis of proliferative neovascular retinopathies and the role of vitrectomy. A hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2973518-4

7 January 2021

Prognostic value of vitreous findings in diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2973518-4

7 January 2021

Closed Vitrectomy in the Management of Diabetic Traction Retinal Detachment

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2973518-4

7 January 2021

A new concept for vitreous surgery. I. Instrumentation

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2973518-4

7 January 2021

Vitrectomy for Complications of Diabetic Retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2973518-4

7 January 2021

Long-term diabetic vitrectomy results. Report of 10 year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2973518-4

7 January 2021

Pars plana vitrectomy techniques for relief of epiretinal traction by membrane segmentation

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2973518-4

7 January 2021

Results of vitrectomy for diabetic traction retinal detachments using the en bloc excision technique

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2973518-4

7 January 2021

Pars plana vitrectomy for complicated retinal detachments

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2973518-4

7 January 2021

Pars Plana Vitrectomy for Diabetic Traction Retinal Detachment

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2973518-4

7 January 2021

Vitrectomy for Proliferative Diabetic Retinopathy Associated with Vitreous Hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2973518-4

7 January 2021

Vitrectomy for Diabetic Traction Retinal Detachment Involving the Macula

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2973518-4

7 January 2021

Vitrectomy for diabetic rhegmatogenous retinal detachment

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2973518-4

7 January 2021

Results and prognostic factors in vitrectomy for diabetic traction retinal detachment of the macula

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2973518-4

7 January 2021

Results and prognostic factors in vitrectomy for diabetic vitreous hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2973518-4

7 January 2021

Results and prognostic factors in vitrectomy for diabetic traction-rhegmatogenous retinal detachment

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2973518-4

7 January 2021

An activated form of transforming growth factor beta is produced by cocultures of endothelial cells and pericytes

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2973518-4

7 January 2021

Two-year course of visual acuity in severe proliferative diabetic retinopathy with conventional management. Diabetic Retinopathy Vitrectomy Study (DRVS) report #1

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2973518-4

7 January 2021

Early vitrectomy for severe proliferative diabetic retinopathy in eyes with useful vision. Results of a randomized trial--Diabetic Retinopathy Vitrectomy Study Report 3. The Diabetic Retinopathy Vitrectomy Study Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2973518-4

7 January 2021

Early vitrectomy for severe proliferative diabetic retinopathy in eyes with useful vision. Clinical application of results of a randomized trial--Diabetic Retinopathy Vitrectomy Study Report 4. The Diabetic Retinopathy Vitrectomy Study Research Grou

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2973518-4

7 January 2021

The natural history of diabetic extramacular traction retinal detachment

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2973518-4

7 January 2021

The Effect of Lensectomy on the Incidence of Iris Neovascularization and Neovascular Glaucoma After Vitrectomy for Diabetic Retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2973518-4

7 January 2021

The lens influence on diabetic vitrectomy results. Report of a prospective randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2973518-4

7 January 2021

Intraoperative argon endophotocoagulation for recurrent vitreous hemorrhage after vitrectomy for diabetic retinopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2973518-4

7 January 2021

Changing indications and techniques for vitrectomy in management of complications of diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2973518-4

7 January 2021

Diabetic dense premacular hemorrhage. A possible indication for prompt vitrectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2973518-4

7 January 2021

Timing of vitrectomy for active proliferative diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2973518-4

7 January 2021

Vitrectomy for progressive macular traction associated with proliferative diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2973518-4

7 January 2021

Silicone oil for progressive anterior ocular neovascularization after failed diabetic vitrectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2973518-4

7 January 2021

Reoperation following diabetic vitrectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2973518-4

7 January 2021

10.1016/S0002-9394(14)73518-4

Identifiers

DOI

0 references

PubMed ID

8420359

1 reference

PubMed ID

8420359